The human epidermal growth factor receptor protein tyrosine kinase family, including EGFR and HER2, has emerged as an important therapeutic target for non-small cell lung cancer, breast cancer, and gastroesophageal cancer (1, 2). This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.